197 related articles for article (PubMed ID: 3925742)
21. Ointments and transdermal nitroglycerin patches for stable angina pectoris.
Thadani U; Lipicky RJ
Cardiovasc Drugs Ther; 1994 Aug; 8(4):625-33. PubMed ID: 7848897
[TBL] [Abstract][Full Text] [Related]
22. Nitrate tolerance. A problem during continuous nitrate administration.
Parker JO
Eur J Clin Pharmacol; 1990; 38 Suppl 1():S21-5. PubMed ID: 2113001
[TBL] [Abstract][Full Text] [Related]
23. Nitrate tolerance.
Parker JO
Herz; 1984 Jun; 9(3):137-45. PubMed ID: 6430767
[TBL] [Abstract][Full Text] [Related]
24. Pharmacology of nitroglycerin and long-acting nitrates.
Abrams J
Am J Cardiol; 1985 Jul; 56(2):12A-18A. PubMed ID: 3925750
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of interval nitrate therapy in angina pectoris.
Rudolph W; Dirschinger J; Hall D; Reiniger G; Bayeric A
Eur Heart J; 1989 May; 10 Suppl A():50-5. PubMed ID: 2501095
[TBL] [Abstract][Full Text] [Related]
26. Assessment of dermal glyceryl trinitrate and isosorbide dinitrate for patients with angina pectoris.
Hubner PJ; Jones PR; Galer IA
Br Med J (Clin Res Ed); 1985 Feb; 290(6467):514-6. PubMed ID: 3918653
[TBL] [Abstract][Full Text] [Related]
27. Letter: Treatment of angina pectoris.
Cohn K
Circulation; 1974 May; 49(5):1015-6. PubMed ID: 4208181
[No Abstract] [Full Text] [Related]
28. Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure.
Elkayam U; Roth A; Mehra A; Ostrzega E; Shotan A; Kulick D; Jamison M; Johnston JV; Rahimtoola SH
Circulation; 1991 Nov; 84(5):2040-8. PubMed ID: 1934379
[TBL] [Abstract][Full Text] [Related]
29. Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.
Thadani U; Whitsett T
Clin Pharmacokinet; 1988 Jul; 15(1):32-43. PubMed ID: 3135973
[TBL] [Abstract][Full Text] [Related]
30. Letter: Treatment of angina pectoris.
Goldstein RE; Epstein SE
Circulation; 1974 May; 49(5):1016-7. PubMed ID: 4208182
[No Abstract] [Full Text] [Related]
31. Clinical relevance of nitrate hemodynamic attenuation.
Flaherty JT
Am Heart J; 1986 Jul; 112(1):216-20. PubMed ID: 3088959
[No Abstract] [Full Text] [Related]
32. Nitrate tolerance: does tid isosorbide dinitrate mean dosing every eight hours?
O'Quinn SV; Figg WD
DICP; 1991 Nov; 25(11):1272-3. PubMed ID: 1763550
[No Abstract] [Full Text] [Related]
33. Hemodynamic attenuation and the nitrate-free interval: alternative dosing strategies for transdermal nitroglycerin.
Flaherty JT
Am J Cardiol; 1985 Dec; 56(17):32I-37I. PubMed ID: 3000161
[TBL] [Abstract][Full Text] [Related]
34. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
Kośmicki M; Szwed H; Kowalik I; Sadowski Z
Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of isosorbide mononitrate in angina pectoris.
Thadani U; de Vane PJ
Am J Cardiol; 1992 Nov; 70(17):67G-71G. PubMed ID: 1449103
[TBL] [Abstract][Full Text] [Related]
36. Nitrate tolerance: influence of isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerin.
Dalal JJ; Yao L; Parker JO
J Am Coll Cardiol; 1983 Jul; 2(1):115-20. PubMed ID: 6406586
[No Abstract] [Full Text] [Related]
37. Hemodynamic effects of nitroglycerin and long-acting nitrates.
Abrams J
Am Heart J; 1985 Jul; 110(1 Pt 2):216-24. PubMed ID: 3925741
[TBL] [Abstract][Full Text] [Related]
38. A practical guide to nitrate use.
Anderson KA
Postgrad Med; 1991 Jan; 89(1):67-70, 75-6, 78. PubMed ID: 1898677
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of isosorbide dinitrate and nitroglycerin in relieving angina pectoris during uninterrupted exercise.
Kattus AA; Alvaro AB; Coulson A
Chest; 1975 Jun; 67(6):640-6. PubMed ID: 805037
[TBL] [Abstract][Full Text] [Related]
40. Acute and chronic isosorbide dinitrate therapy in congestive heart failure: demonstration of improved exercise capacity and differing arterial and venous tolerance during chronic administration.
Leier CV; Huss P; Magorien RD; Unverferth DV
Z Kardiol; 1983; 72 Suppl 3():173-7. PubMed ID: 6666218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
